No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
None.
No insider has filed a notice of proposed sale (Form 144) for Provectus Biopharmaceuticals Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
HF
Home Federal Bank Of Tennessee
|
100.0K | 0.02% | Unchanged | ≤2021 | 0.0% | |
|
Shares held by quarter
Peak holding100.0K (Q3'24)
Change over 8 quarters0
Share of the company0.020%
|
||||||
|
WP
Wealth Preservation Advisors, LLC
|
— | — | SOLD OUT | — | 0.0% | |
|
Shares held by quarter
Peak holding52.6K (Q3'25)
Change over 8 quarters0
|
||||||
3 more super investors behind a free account
See every manager holding Provectus Biopharmaceuticals Inc, how their position has changed, and how long they've held it.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PE
Pershing Edward
5%+ holder
13D · 11.6%
|
52.4M | 12.48% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
DR
Dominic Rodrigues
5%+ holder
13D · 5.7%
|
25.2M | 6.00% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...